期刊文献+

脓毒症患者血清C-反应蛋白、皮质醇的动态变化及其与预后的关系 被引量:7

Dynamic changes of C-reactive protein and cortisol in patients with sepsis and their relationship with prognosis
下载PDF
导出
摘要 目的:研究脓毒症患者血清C-反应蛋白(CRP)、皮质醇(COR)的动态变化特点及其对脓毒症患者预后评估的临床价值。方法:97例脓毒症患者住ICU期间每天采血进行CRP、COR检测,记录CRP、COR的动态变化。分析患者血清CRP、COR的动态变化特点及其与预后的关系。结果:治疗后病死患者的血清CRP和COR水平显著高于存活患者(P<0.05)。按CRP、COR动态变化趋势的不同分为4种类型:Ⅰ型:持续升高型;Ⅱ型:升高-回落型;Ⅲ型:反复波动型;Ⅳ型:正常或轻度升高型。CRPⅠ型患者的病死率显著高于CRPⅡ型和CRPⅣ型(P<0.001)。CORⅠ型、CORⅢ型患者的病死率分别显著高于CORⅡ型和CORⅣ型(P<0.001)。进一步分析,CRP和COR均明显升高组的病死率显著高于CRP或COR任一明显升高组及CRP和COR均非明显升高组(P<0.001);CRP或COR任一明显升高组的病死率亦显著高于CRP和COR均非明显升高组(P<0.001)。结论 :脓毒症患者CRP、COR的动态变化有一定的特点,监测两者的动态变化能够对脓毒症的预后做出较准确的评估。 Objective To study the dynamic changes of plasma C-reactive protein (CRP) and cortisol (COR) and their chnical value in prognosis of patients with sepsis. Methods Daily CRP and COR detection was conducted to record the dynamic changes of CRP and COR for cases of sepsis patients in ICU then the rela- tionship between dynamic changes of serum CRP and COR and prognosis were analyzed. Results Serum CRP and COR levels of dead patients were significantly higher than those of survival patients after treatment (P 〈 0.05). According to the difference of the dynamic changes of CRP and COR, the data were divided into type Ⅰ : sustained elevated type, type Ⅱ : up-and-down type, type Ⅲ fluctuated type and type Ⅳ : normal or mild elevation type. The mortality of CRP type Ⅰ patients was significantly higher than that of type Ⅱ and type IV (P 〈 0.001 ). The mortality of COR type I and COR Ⅲ patients was significantly higher than that in COR I/and COR IV (P 〈 0.001). Further analysis showed that the mortality of group with significant elevation of CRP and COR were obviously higher than that of group with significant increase of CRP or COR and that of group with no significant elevation of CRP and COR (P 〈 0.001 ) ; the mortality of group with significant increase of CRP or COR was also significantly higher than that of group with no significant elevation of CRP and COR (P 〈 0.001 ). Conclusions The dynamic changes of COR and CRP in patients with sepsis present certain regularity and monitoring the dynamic changes of the two provides accurate assessment of the prognosis of sepsis.
出处 《实用医学杂志》 CAS 北大核心 2015年第23期3909-3912,共4页 The Journal of Practical Medicine
基金 梧州市科技计划项目(编号:201202073)
关键词 脓毒症 C-反应蛋白 皮质醇 Sepsis C-reactive protein Cortisol
  • 相关文献

参考文献11

  • 1Singh B, Chaudhuri TK. Role of C-reactive protein in schizophre- nia: an overview [J]. Psychiatry Res, 2014,216(2) :277-285.
  • 2Ryu JA, Yang JH, Lee D, et al. Clinical usefulness of procalci- tonin and C-reactive protein as outcome predictors in critically ill patients with severe sepsis and septic shock [J]. PloS One, 2015, 10(9) : 138-150.
  • 3周少丽,谭芳,陈裕洁.右美托咪定用于治疗脓毒症的研究及其进展[J].实用医学杂志,2013,29(15):2421-2422. 被引量:17
  • 4Levy MM, Fink MP, Marshall JC, et al. 2011 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference [ J ]. Crit Care Med, 2003,31(4) : 1250-1256.
  • 5Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) [J]. Ann Intern Med, 1996,125(8) :680-687.
  • 6Ciriello V, Gudipati S, Stavrou PZ, et al. Biomarkers pre-dicting sepsis in polytrauma patients: current evidence [J]. Injury, 2013,44(12) : 1680-1692.
  • 7Boonen E, Vervenne H, Meersseman P, et al. Reduced cortisol metabolism during critical illness [J]. N Engl J Med, 2013,368 (16) : 1477-1488.
  • 8黄道永,饶惠清,周敦荣,姜悦,周瑶蓝.连续性血液净化抢救严重脓毒症患者的临床评价[J].现代医院,2013,13(1):35-37. 被引量:16
  • 9陆莹,肖刚.多器官功能障碍综合征发病机制研究新进展[J].中国急救医学,2014,34(12):1150-1152. 被引量:11
  • 10徐欣晖,朱长清.“相对性”肾上腺皮质功能不全再认识[J].医学综述,2015,21(7):1161-1163. 被引量:5

二级参考文献41

  • 1Anca Trifan,Stefan Chiriac,Carol Stanciu.Update on adrenal insufficiency in patients with liver cirrhosis[J].World Journal of Gastroenterology,2013,19(4):445-456. 被引量:11
  • 2Jia-Kui Sun,Xin-Wei Mu,Wei-Qin Li,Zhi-Hui Tong,Jing Li,Shu-Yun Zheng.Effects of early enteral nutrition on immune function of severe acute pancreatitis patients[J].World Journal of Gastroenterology,2013,19(6):917-922. 被引量:107
  • 3HEIDEKMANN S M, OFENSTEIN J P, SARNAIK A P. Efficacy of continuous arteriovenous hemofihration in endotoxic shock [ J ]. Circ Shock, 1994,44 : 183.
  • 4ROGIERS P, ZHANG H, SMAIL N, et al. Highvolume hemofiltra- tion improves hemodnamics in experimental endotoxic shock [ J ]. Intensive Care Med, 1996,22 : $396.
  • 5LONNEMANN G, LINNENWEBER S, BURG M, et al. Tranfer of endogenous pyrogens across artificial membranes[ J]. Kidney Int, 1998,53( supple 66) :43 -46.
  • 6PASCUAL M, TOLK OFF - RUBIN N, SCHIFFERLI J A. Is ad- sorption an important cha - racteristic of dialysis membranes [ J ]. Kidney Int, 1996,49:309.
  • 7RONCO C,INGUAGGIATO P, D'INTINI V, et al. The role of ex- tracorporeal therapies in sepsis [ J ]. J Nephrol, 2002,16 : $34 - $41.
  • 8Webster N R, Galley H F. Immunomodulation in the critically ill [J]. Br J Anaesth, 2009,103(1):70-$1.
  • 9Riker R R, Shehabi Y, Bokesch P M, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial [ J ]. JAMA, 2009,301 (5) : 489-499.
  • 10Yang C L, Tsai P S, Huang C J. Effects of dexmedetomidine on regulating pulmonary inflammation in a rat model of ventila- tor-induced lung injury [J]. Acta Anaesthesiol Taiwan, 2008, 46(4) : 151-159.

共引文献73

同被引文献56

  • 1RYU JA, YANG JH, LEE D, et al. Clinical usefulness of procalcitonin and C-reactive protein as outcome predictors in critically ill patients with severe sepsis and septic shock [J]. PLoS One, 2015,10(9) : 138-150.
  • 2VAN LANDEGHEM L, CHEVALIER J, MAH6 MM, et al. Enteric glia pro-mote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGF [J]. Am J Physiol Gastrointestinal Liver Physiol, 2011,300 (6) : 976-987.
  • 3LIU F, CHEN Z, WANG J, et 81. Over-expression of cell surface cy- tokeratin 8 in muhidmg-resistant MCF- 7/MX cells enhances celladhesion to the extracellular matrix [J]. Neoplasia, 2008,10( 11 ) : 1275-1284.
  • 4NEUNLIST M, VAN LANDEGHEM L, BOURREILLE A, et al. Neuro- glialerosstalk in inflammatory bowel disease [J]. J Intern Med, 2008,263 (6) : 577-583.
  • 5LEVY MM, FINK MP, MARSHALL JC, et al. 2001 sceM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference [J]. Crit care Med, 2003, 31 (4) : 1250-1256.
  • 6HU YM, YEH CL, PAI MH, et al. Glutamine administration modulates lung γδ T lymphocyte expression in mice with polymicrobial sepsis [J]. Shock, 2014,41 (2) : 115-122.
  • 7OUDEMANS-VAN STRAATEN HM, VAN ZANTEN AR. Glutamine supplementation in the critically ill: friend or foe [J]. Crit Care, 2014,18 (3) : 143.
  • 8杨海波,邓杰,颜波儿,林旭波.脓毒症患者甲状腺激素、皮质醇水平变化与预后的关系[J].现代实用医学,2008,20(3):176-177. 被引量:1
  • 9刘霞,黄绮薇.脓毒症新生儿肾上腺皮质功能的研究[J].临床儿科杂志,2009,27(3):239-242. 被引量:8
  • 10董丽宏.皮质醇和促肾上腺皮质激素在危重症患者血清中的变化及临床意义[J].细胞与分子免疫学杂志,2010,26(11):1118-1119. 被引量:12

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部